Moderna Inc
-
{
- All
- News
-
Moderna Says Its Covid Shot Produces Antibodies Against Delta Variant
Moderna Inc. said its vaccine produced protective antibodies against the delta variant spreading in the U.S. and many other parts of the world.
-
AstraZeneca Sold Its Stake In Moderna For More Than $1 Billion: Report
AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion after the U.S. biotechnology company's shares soared on the back of its coronavirus vaccine breakthrough, The Times reported.
-
Moderna Vs Pfizer: When Will The Vaccines Be Ready?
The first two Covid-19 vaccines out of the gate have now delivered positive news in the quest to end the pandemic. The encouraging late-stage trial results from Pfizer Inc. and Moderna Inc. set a high bar for rivals such as AstraZeneca Plc that are expected to follow soon with their own pivotal reports.
-
Promising COVID-19 Vaccine Sends Drug Firm's Shares Soaring
Moderna Inc said on Monday its experimental COVID-19 vaccine showed promise in a small early-stage trial, with the vaccine producing virus-neutralizing antibodies similar to that found in recovered patients, sending shares soaring 25%.
-
Moderna Says Its Covid Shot Produces Antibodies Against Delta Variant
Moderna Inc. said its vaccine produced protective antibodies against the delta variant spreading in the U.S. and many other parts of the world.
-
AstraZeneca Sold Its Stake In Moderna For More Than $1 Billion: Report
AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion after the U.S. biotechnology company's shares soared on the back of its coronavirus vaccine breakthrough, The Times reported.
-
Moderna Vs Pfizer: When Will The Vaccines Be Ready?
The first two Covid-19 vaccines out of the gate have now delivered positive news in the quest to end the pandemic. The encouraging late-stage trial results from Pfizer Inc. and Moderna Inc. set a high bar for rivals such as AstraZeneca Plc that are expected to follow soon with their own pivotal reports.
-
Promising COVID-19 Vaccine Sends Drug Firm's Shares Soaring
Moderna Inc said on Monday its experimental COVID-19 vaccine showed promise in a small early-stage trial, with the vaccine producing virus-neutralizing antibodies similar to that found in recovered patients, sending shares soaring 25%.
